학술논문

A U.S. Food and Drug Administration–pooled Analysis of Frontline Combination Treatment Survival Benefits by Risk Groups in Metastatic Renal Cell Carcinoma
Document Type
Article
Source
In: European Urology. (European Urology, October 2023, 84(4):373-378)
Subject
Language
English
ISSN
18737560
03022838